US 10308687
Cell-penetrating compstatin analogs and uses thereof
granted A61KA61K38/00A61K47/645
Quick answer
US patent 10308687 (Cell-penetrating compstatin analogs and uses thereof) held by Apellis Pharmaceuticals, Inc. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61K47/645